Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pulse Biosciences (PLSE) Cash from Investing Activities (2020 - 2025)

Pulse Biosciences (PLSE) has 6 years of Cash from Investing Activities data on record, last reported at -$105000.0 in Q4 2025.

  • For Q4 2025, Cash from Investing Activities fell 98.11% year-over-year to -$105000.0; the TTM value through Dec 2025 reached -$335000.0, down 168.0%, while the annual FY2025 figure was -$335000.0, 168.0% down from the prior year.
  • Cash from Investing Activities reached -$105000.0 in Q4 2025 per PLSE's latest filing, down from -$62000.0 in the prior quarter.
  • Across five years, Cash from Investing Activities topped out at $7.9 million in Q1 2021 and bottomed at -$279000.0 in Q1 2022.
  • Average Cash from Investing Activities over 5 years is $329050.0, with a median of -$44000.0 recorded in 2023.
  • Peak YoY movement for Cash from Investing Activities: surged 99.3% in 2021, then tumbled 800.0% in 2025.
  • A 5-year view of Cash from Investing Activities shows it stood at -$134000.0 in 2021, then soared by 69.4% to -$41000.0 in 2022, then fell by 4.88% to -$43000.0 in 2023, then decreased by 23.26% to -$53000.0 in 2024, then plummeted by 98.11% to -$105000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Cash from Investing Activities were -$105000.0 in Q4 2025, -$62000.0 in Q3 2025, and -$123000.0 in Q2 2025.